Modulation of Vasomotive Activity in Rabbit External Ophthalmic
Artery by Neuropeptides by Delgado, Esmeralda Sofia Costa et al.
Hindawi Publishing Corporation
Journal of Ophthalmology
Volume 2012, Article ID 498565, 6 pages
doi:10.1155/2012/498565
Research Article
ModulationofVasomotiveActivityinRabbitExternal
OphthalmicArtery byNeuropeptides
EsmeraldaSoﬁaCostaDelgado,1 CarlosMarques-Neves,2 MariaIsabel SousaRocha,2
Jos´ e PauloPacheco Sales-Lu´ ıs,1 and Lu´ ısFilipeSilva-Carvalho2
1Clinical Department, CIISA, Faculty of Veterinary Medicine, Technical University of Lisbon, Alameda da Universidade T´ ecnica,
1300-477 Lisbon, Portugal
2Instituto de Medicina Molecular and Instituto de Fisiologia, Faculdade de Medicina, Universidade de Lisboa,
Avenida Professor Egas Moniz, 1649-028 Lisbon, Portugal
Correspondence should be addressed to Esmeralda Soﬁa Costa Delgado, esmeralda@fmv.utl.pt
Received 8 August 2011; Revised 1 November 2011; Accepted 3 November 2011
Academic Editor: Shintaro Nakao
Copyright © 2012 Esmeralda Soﬁa Costa Delgado et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Purpose. To investigate the vasomotive activity upon the external ophthalmic artery of vasointestinal peptide (VIP) and
neuropeptide Y(NPY)usingapreviouslydevelopedmodel.Methods.Isolatedrabbiteyes (n = 12)wereperfused insitu withtyrode
through the external ophthalmic artery. Eﬀects of intra-arterial injections of NPY 200µg/ml (Group A; n = 6) and VIP 200µg/ml
(GroupB;n = 6)ontherecorded pressurewereobtained.Forstatisticalanalysis,Student’spairedt-test andFast Fourier Transform
were used. Results. Spontaneousoscillationswere observed before any drug administrationinthe 12rabbitmodels.NPY produced
an increase in total vascular resistance and a higher frequency and amplitude of oscillations,while VIP evokedthe opposite eﬀects.
Conclusions.Thisstudy provides evidence ofvasomotioninbasalconditionsinrabbitexternal ophthalmicartery. Concerningdrug
eﬀects, NPY increased arterial resistance and enhanced vasomotionwhile VIP produced opposite eﬀects which demonstrates their
profound inﬂuence in arterial vasomotion.
1.Introduction
Disturbances ofocular blood ﬂow are involvedin many oph-
thalmic diseases and therefore are of the utmost clinical
relevance. The eye is one of the best perfused organs in the
body. In humans and in experimental animals, the eye has
two separate systems of blood vessels, which anatomically
and physiologically diﬀer: the retinal vessels, which supply
partoftheretina, andtheuvealorciliarybloodvessels,which
supply the rest of the eye. There is autonomic innervation of
the extraocular vessels as well as of choroidal vessels [1, 2].
In primates, innervation of the central artery occurs as far
as to the lamina cribrosa. There is no innervation of vessels
ofthe retina although alpha, beta-adrenergic and cholinergic
receptors are present [3, 4]. There are studies describing
some innervation of the optic nerve head [5].
Besides there is mounting evidence that the retinal blood
vesselshavereceptorsforandsensitivity toneurotransmitters
and neurohormones, including biologically active peptides
[6, 7]. NPY and VIP are two neuropeptides that occur in pe-
ripheral nerves supplying both the eye and blood vessels to
the brain [7, 8].
Vasoactive intestinal peptide (VIP) is a peptide hormone
containing28aminoacidresidues producedin many areas of
thehumanbodyincludingthegut,pancreas,andsuprachias-
matic nuclei of the hypothalamus in the brain and is neuro-
protective [9].
Neuropeptide Y (NPY) is a 36-amino acid peptide neu-
rotransmitter found in the brain and autonomous nervous
system, secreted by the hypothalamus, and it has been
associated with several physiologic processes in the brain,
blocking nociceptive signals and augmenting the vasocon-
strictor eﬀects of noradrenergic neurons [10].
They are both vasoactive, VIP nerve ﬁbers are parasym-
pathetic causing vasodilation, and NPY is generally asso-
ciated with the sympathetics, although it is also found in2 Journal of Ophthalmology
some parasympathetic neuronssupplying the eye,suggesting
am i x e da u t o n o m i co r i g i n[ 7]. In several organs, VIP seems
tobecolocalizedwith neuronalNOSandthesame holdstrue
for nitrergic choroidal innervation [11].
In this work, we used an isolated model ofrabbiteye pre-
viously developed [12] to study the evoked vasomotor re-
sponses with NPY and VIP intra-arterial administration
upon perfusion pressure and periodic oscillations at the rab-
bit external ophthalmic artery in vitro.
2.Methods
2.1. Anaesthesia and Surgical Procedures. Twelve hybrid
NewZealand rabbits of either sex were used, weighing be-
tween 2,10Kg and 3,90Kg, mean 3,20 ± 0.157Kg, anaes-
thetized with pentobarbital sodium (40mg/Kg body weight
iv, Eutasil, Sanoﬁ, Portugal), supplemented as necessary,
tracheostomised and artiﬁcially ventilated with O2-enriched
air applied using a positive pressure ventilator (Harvard
Apparatus Ltd, UK). Body temperature was monitored and
maintained constant (38-39◦C) by using a servocontrolled
heating blanket (Harvard Apparatus Ltd, UK). The external
carotid artery and jugular vein were cannulated for the
administration of drugs and bleeding, respectively. During
the surgical procedures, arterial pressure (Neurolog System,
Digitimer,UK),respiratoryrate,andECG(NeurologSystem,
Digitimer, UK) were monitored to assess the depth of
anaesthesia. Heparin (1000UI/Kg) was perfused through
the external carotid artery, and a waiting time of 20min
was respected. After that euthanasia was performed with an
overdose of pentobarbital sodium, the head was sectioned at
cervical level and perfusion was commenced at the external
carotid artery. Encephalon and intact cranial nerves were
mechanically destroyed using a scalpel blade that entered
the cranium through the foramen magnum, to ensure that
the interference of stimuli originating outside the ocular
globe in the central nervous system and the autonomous
nervoussystem was abolished. The protocolsand procedures
were approved by the University Ethics Committee and
conformed to the Helsinki Declaration.
2.2. Isolated Eye Model. External ophthalmic arteries were
exposed, and a 0,6mm outside diameter polypropylene tube
wasplacedin thevesselswith theaidofasurgicalmicroscope
(Shin Nippon, Japan). The three-way catheter was further
connected to a continuous intravenous infusion apparatus
(Semat,series81706,UK)andtoapressure transducer(Neu-
rolog System, Digitimer, UK). The eﬀect of intraluminal
pressure as a measure of total vascular resistance was as-
sessed. The head was maintained immerse in a glass chamber
containing O2-enriched tyrode at a constant temperature
of 38◦C and controlled pH. Continuous infusion was com-
menced at a ﬂow rate of 135µL/min.
There was a period between the death of the animal and
the beginning of the experiment that corresponded to 40.6
± 0.93 minutes in Group A and 39.4 ± 0.93 minutes in
Group B (n = 12,P = 0.387). Once perfusion commenced,
an equilibration period was respected that corresponded to
16.0 ± 0.71 minutes in Group A and 15.4 ± 0.51 minutes
in Group B (n = 12,P = 0.511). On what concerns the
total time of an experiment, from the euthanasia of the
animal until the end of the experiment, it was 110.4 ± 2.42
minutes in Group A and 109,2 ± 2,13 minutes in Group
B( n = 12,P = 0.719). Since P values were greater than
0.05, diﬀerences were considered not signiﬁcant, that is, the
diﬀerence between means is not signiﬁcantly greater than
expected by chance.
2.3. Drug Injections. In group A (n = 6), response curves
to three injections of NPY in a concentration of 200µg/mL
[13]w e r eo b t a i n e d .I ng r o u pB( n = 6), response curves to
three injections of VIP [13]i nac o n c e n t r a t i o no f2 0 0µg/mL
were obtained. Injections were given intra-arterially in a
volume of 0.1mL in a system derivation, with a 20-minute
interval and the waiting time respected intended to allow the
pressuretoreturntoastablebaseline.Intheend,thepressure
w a sc a l i b r a t e dt oav a l u eo f4 0 m m H gt oa d j u s tp r e s s u r e
values obtained. Finally, methylene blue dye was injected
through the ophthalmic artery to conﬁrm eye perfusion by
blue staining.
2.4. Drugs and Solutions. Tyrode solution comprises NaCl
(137mM), KCl (2.7mM), CaCl2 (1.8mM), MgCl2
(0.49mM), NaH2PO4 (0.36mM), NaHCO3 (11.9mM), glu-
cose (5.6mM), and distilled water (1L). NPY (N9409) and
VIP (V6130) both from Sigma Aldrich Chemie Gmbh P. O.
1120, 89552 Steinheim, Germany, were diluted in distilled
water and freshly prepared.
2.5. Data Analysis. For the variables recorded, the baseline
values were taken immediately before the beginning of the
injectionandcomparedwiththeonesobtainedinthepeakof
the response. Perfusion pressure, frequency, and amplitude
of the oscillations were evaluated before and after the drug
injections. All recorded variables were digitised (Instrutech
VR100B, Digitimer Ltd, UK) and recorded on videotape.
Oﬀ-line analysis was done using a computer A/D system
with data capture and analysis software (Chart for Windows,
5.0, USA). Data were analysed with GraphPad (InStat,
version 3.00 for Windows 95, GraphPad Software, San Diego
California USA) and are reported as mean ± standard error.
Student’s t-test for paired comparisons were performed to
compare values obtained before and after the drug injections
forperfusion pressure, frequency,and amplitudeoftheoscil-
lationswithP<0.05testingforsigniﬁcance.Dataweretested
for normal distribution with the Kolmogoroﬀ-Smirnoﬀ test.
Episodes of vasomotion were recorded, and the ampli-
tudes and frequencies of the oscillations were characterized
by fast fourier analysis. The frequency spectra of the oscilla-
tions are expressed in Hertz (Hz).
3.Results
3.1. SpontaneousOscillations. Without any drug administra-
tion, spontaneous myogenic responses were observed in the
12rabbitmodelsshowingoscillationsofamediumfrequencyJournal of Ophthalmology 3
Table 1: PP: Perfusion Pressure (mmHg); Freq: Frequency of oscillations(number oscillations/min);Ampl: Amplitude of oscillations(mm
Hg); NPY = Neuropeptide Y.
Group A
Basal First NPY P Basal Second NPY P Basal Third NPY P
PP 9.1 ±1.67 19.2 ± 3.49 <0.015 11.9 ±1.66 15.9 ±2.49 <0.008 10.7 ± 1.29 16.5 ±2.23 <0.015
Freq 10.4 ±5.00 19.2 ± 9.27 <0.002 7.2 ±4.35 17.7 ±8.83 0.034 5.7 ± 3.54 13.5 ±7.38 0.011
Ampl 1.4 ±0.73 2.7 ± 1.17 <0.021 0.7 ±0.26 1.9 ±0.71 <0.01 0.3 ± 0.06 0.7 ±0.12 <0.01
Table 2: PP: Perfusion Pressure (mmHg); Freq: Frequency of oscillations (number oscillations/min); Ampl: Amplitude of oscillations
( m mH g ) ;V I P :V a s o i n t e s t i n a lP e p t i d e .
Group B
Basal First VIP P Basal Second VIP P Basal Third VIP P
PP 23.9 ±6.98 15.4 ±4.31 <0.006 20.8 ± 5.40 12.9 ±3.14 <0.004 18.6 ± 4.32 12.2 ±3.37 0.001
Freq 13.6 ±7.14 8.3 ±5.00 0.001 9.8 ± 5.18 5.9 ±3.80 0.015 7.8 ± 4.06 3.7 ±2.16 0.004
Amp 2.7 ±1.53 1.9 ±1.17 0.050 2.4 ± 1.39 1.7 ±1.11 <0.032 2.0 ± 1.23 1.5 ±1.13 0.004
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Figure 1: Example of basal periodic oscillations in vascular tone
observed before any drug administration. On the x axis, the perfu-
sionpressure recorded attherabbitexternal ophthalmicartery isre-
presented inmmHg. Inthe y axis,werepresent thetimeinseconds.
of 7.7 ± 1.71 oscillations per minute and a medium ampli-
tude value of 2.1 ± 1.13mm Hg (Figure 1).
3.2. NPY and VIP Eﬀects on Perfusion Pressure. In Group
A( n = 6) of experiments we observed that the intra-
arterial delivered NPY elicited vasoconstriction. The ﬁrst
intra-arterial injection of 0.1mL of NPY 200µg/mL evoked
anincreaseof41%,thesecondintra-arterial injectionelicited
an increase of 25%, and the third registered an increase of
35% (Table 1). In Group B (n = 6), the arteries dilated in
response to VIP. With the ﬁrst intra-arterial injection, we
registered a decrease of 29%, with the second administration
a decrease of 29%, and the third evoked a decrease of 27%
(Table 2).
3.3. NPY and VIP Eﬀects on the Frequency of Periodic Oscil-
lations. In Group A, with NPY, the frequency of the oscil-
lations increased. The ﬁrst injection resulted in increase of
36%, the second produced an increase of 47%, and the
third an increase of 40% (Table 1). In Group B, with VIP,
the frequency of the oscillations decreased. With the ﬁrst
intra-arterial injection, we registered a frequency decrease of
35%, with the second a decrease of 46%, and with the third
administration a decrease of 45% (Table 2).
3.4. NPY and VIP Eﬀects on the Amplitude of Periodic Oscil-
lations. In Group A, with NPY, the amplitude of the oscil-
lations increased. With the ﬁrst injection, we registered an
increase of 48%, with the second an increase of 63% and
with the third an increase of 57% (Table 1). In Group B
there was a decrease in the amplitude of the oscillations. The
ﬁrst injection of VIP made the amplitude of the oscillations
decrease 30%, the second elicited a decrease of 29%, and the
third a decrease of 25%(P = 0.004) (Table 2, Figure 2).
3.5. Fast Fourier Analysis. As a result of the mathematical
analysis with Fast Fourier Transform, a power spectrum
density (PSD)was built for each rabbit.The most prominent
frequency was considered as the principal frequency and was
used to characterize the vasomotion pattern. The frequency
spectrums illustrated the results displayed in Figure 3,
although we could see the presence of several superimposed
frequencies. So there was a marked increase in the frequency
of the oscillations with NPY and a decrease following VIP
administration (Figure 3).
4.Discussion
In this study, we characterized the reactivity of rabbit ocular
vasculature to intraluminal pressure by perfusing the feeding
external ophthalmic artery in a head-mounted preparation.
This, thus, ruled out a central nervous system (CNS) media-
tion and led the authors to postulate that this in vitro model
abolished the interference of stimuli originating outside the
ocular globe, through the CNS, therefore proved that the
spontaneous oscillations observed in basal conditions were
independent of central regulation, being interpreted as vaso-
motion [12].
However, one cannot interpret this ex vivo model as rep-
resenting a purely vasomotor paradigm devoid of any auto-
nomic innervation. There are some 20 intrinsic choroidal
neurons in the rabbit eye [11], and the sphenopalatine gan-
glion still intact in this preparation may receive trigeminal
peptidergic collaterals also in the rabbit as it does in the rat.4 Journal of Ophthalmology
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Figure 2: Example of changes in vascular tone observed after an intra-arterial injection of NPY in group A, causing vasoconstriction and
increase in frequency and amplitude of the oscillations.We can see an example of an eﬀect of an intra-arterial injection of VIP in perfusion
pressure, producing vasodilationand decrease in frequency and amplitude of the oscillations.On the x axis, the perfusion pressure recorded
at the rabbit external ophthalmic artery is represented in mmHg. In the y axis, we represent the time in seconds.
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Figure 3: In the upper panel, the power spectrum density (PSD) of basal spontaneous oscillations obtained as a result of mathematical
analysis with the Fast Fourier algorithm shows a major band at 0.12Hz. In the middle panel, the power spectrum density obtained after
Fourier analysis of the oscillations after NPY injection shows a major band around 0.28Hz which results in an increase in the frequency of
the oscillations, so there was a marked increase in the frequency of the spontaneous oscillations. In the lower panel, the power spectrum
density obtained after VIP injection shows a peak frequency of 0.08Hz, so there was a decrease in the frequency of the spontaneous
oscillations.
The brain vasculature was shown to be one target structure
for the innervated principal cells in the sphenopalatine gan-
glion [14], so ocular vasculature could be another target.
Thus, peripheral “pre-central” neuronal reﬂexes may super-
impose on vasomotor activity in the ocular vasculature.
Vasomotion is periodic oscillations in the tone of arteri-
olesresultinginanintermittentsupplyofbloodtoindividual
microcirculatory units, facilitating oxygenation of tissues
near prevenular capillaries [15]. The phenomenon is there-
fore assumed to play an important role in microcirculation.Journal of Ophthalmology 5
In retinal microcirculation [16] and in isolated bovine [17]
and porcine [18] retinal arterioles, the presence of vasomo-
tion has been demonstrated. Recently, it has been proposed
that disturbances in vasomotion might be important factors
inthedevelopmentofretinal lesionsin diabeticmaculopathy
[19]. Therefore, a further characterization of vasomotion in
ocular arteries is pertinent.
Although, in our study, the experimental design cannot
determine the arterial segment responsible for the vaso-
motionobserved,externalophthalmicartery/choroid/retina,
clinical studies use ophthalmic artery haemodynamics as a
measure oftheoverallfunction oftheophthalmiccirculation
[20].
We also quantiﬁed the responses to NPY and VIP, two
neuropeptides that occur in peripheral nerves supplying the
eye [7], by monitoring the perfusion pressure near the entry
point to the eye as a measure of total vascular resistance.
Concerning the eﬀects on vasoreactivity of intra-arterial
administration, NPY and VIP showed opposite eﬀects: NPY
elicited a vasoconstrictor response, and VIP produced vaso-
dilation of the external ophthalmic artery and its collaterals.
These results show that, under in vitro perfusion, eye arteries
present similar responses to NPY and VIP than those ob-
served in in vivo models [21].
Yet previous studies have shown that VIP receptors and
VIP-containing neurons are not uniformly distributed in the
arterial vasculature and that VIP may have selective vasodila-
tory eﬀects [22].
On what regards the eﬀects on vasomotion, NPY pro-
ducedanincreaseintotalvascularresistance andvasomotion
became more evident, exhibiting a higher frequency and
amplitude of oscillations. The evoked vasomotor responses
with VIP were vasodilation and decrease of the frequency
and amplitude of the oscillations of myogenic tone, which
is in favour of a functional role of perivascular peptides in
the control of ocular circulation.
Being so, the results of this investigation have shown
that neuropeptidergic innervation of the rabbit eye has a
profound inﬂuence in arterial vasomotion, which might be
important in diagnosis or therapeutics of ocular ischemic
diseases.
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